Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts

Cellular and Molecular Life Sciences

Volumn 58, Issue 4, 2001, Pages 571-579

  Kitzmann, M ^a   Fernandez, A ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

Cell cycle; MyoD; Myogenesis; Skeletal myoblast; Transition proliferation differentiation

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; GROWTH FACTOR; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; PROTEIN P21; PROTEIN P27; PROTEIN P57; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; GENE INDUCTION; MITOSIS INHIBITION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0035042555     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000882     Document Type: Review

References (103)

1. Ordering S phase and M phase in the cell cycle
2. G1 phase progression: Cycling on cue
3. Inhibitors of mammalian G1 cyclin-dependent kinases
4. The retinoblastoma gene family: Cousin with overlapping interests
5. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation
6. Transcriptional control by the retinoblastoma protein
7. RB kinases and RB-binding proteins: New points of view
8. The E2F transcription factor is a cellular target of the RB protein
9. Regulation of cell proliferation by the E2F transcription factors
10. Control of pRb phosphorylation
11. The MyoD family and myogenesis: Redundancy, networks and thresholds
12. Molecular biology of muscle
13. Expression of a single transfected cDNA converts fibroblasts to myoblasts
14. Myogenin, a factor regulating myogenesis has a domain homologous to MyoD
15. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts
16. Identification of MRF4, a new member of the muscle regulatory factor gene family
17. MyoD1: A nuclear phosphoprotein requiting a myc homology region to convert fibroblasts to myoblasts
18. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes
19. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD
20. Extopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue
21. Pax7 is required for the specification of myogenic satellite cells
22. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo
23. The MyoD DNA binding domain contains a recognition code for muscle specific gene activation
24. Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells
25. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite
26. Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells
27. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
28. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
29. Correlation of terminal cell cycle arrest of sekeltal muscle with induction of p21 by MyoD
30. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells
31. MyoD is required for myogenic stem cell function in adult skeletal muscle
32. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1
33. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation
34. Fos and Jun repress transcriptional activation by myogenin and MyoD: The amino terminus of Jun can mediate prepression
35. Regulation of myogenic differentiation by type beta transforming growth factor
36. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation
37. Growth factor control of skeletal muscle differentiation: Commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor
38. Functional antagonism between c-jun and MyoD proteins: A direct physical association
39. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation on a conserved protein kinase C site in their DNA-binding domains
40. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of conserved threonine residue within the DNA-binding domain
41. Phosphorylation of myogenin in chick myotubes: Regulation by electrical activity and by protein kinase C. Implications for acetylcholine receptor gene expression
42. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
43. Id helix-loop-helix proteins in cell growth and differentiation
44. HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id
45. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
46. Ectopic expression of cyclin D 1 prevents activation of gene transcription by myogenic basic-helix-loop-helix regulators
47. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
48. Inhibition of myogenesis by multiple cyclin-cdk complexes
49. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
50. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation
51. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4
52. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation
53. Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and con function independently
54. Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocyles
55. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD
56. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types
57. Stable expression of antisense Rb-1 RNA inhibits terminal differentiation of mouse myoblast C2 cells
58. MyoD induces retinoblastoma gene expression during myogenic differentiation
59. Requirement for a functional Rb-1 gene in murine development
60. Multiple change in E2F function and regulation occur upon muscle differentiation
61. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1
62. E2F1 inhibition of transcription activation by myogenic basic helix-loop-helix regulators
63. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control
64. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression
65. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members
66. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle
67. p27kip1 is expressed transiently in developing myotomes and enhances myogenesis
68. Induction of p18ink4c and its predominant association with cdk4 and cdk6 during myogenic differentiation
69. p21-containing cyclin kinases exist in both active and inactive states
70. New functional activities for the p21 family of CDK inhibitors
71. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression
72. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity
73. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step
74. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation
75. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes
76. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta: A role for cyclin D1 in control of myoblast differentiation
77. MyoD induces growth arrest independent of differentiation in normal and transformed cells
78. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation
79. The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells
80. Cell cycle-regulated expression of the muscle determination factor Myf-5 in proliferating myoblasts
81. Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates 'reserve cells'
82. The retinoblastoma-like protein p130 is involved in the determination of reserve cells in differentiating myoblasts
83. cdk1- and cdk2-mediated phosphorylation of MyoD Ser 200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity
84. Phosphorylation of nuclear MyoD is required for its rapid degradation
85. Stabilization of MyoD by direct binding to p57(Kip2)
86. P57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts
87. Rapid degradation of the G1 cyclin Cln2 induced by CDK-dependent phosphorylation
88. Degradation mechanism of cell cycle factors by the proteasome
89. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
90. Cyclin E-Cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells
91. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive stage
92. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
93. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
94. Differential roles of p300 and PCAF acetyltransferase in muscle differentiation
95. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
96. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
97. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element
98. Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages
99. A novel myoblast enhancer element mediates MyoD transcription
100. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle
101. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD
102. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
103. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD